Squamous cell vulvar cancer is the most common type of vulvar cancer. It’s often diagnosed in the early stages when it’s found only in the vulva. The main treatment for this cancer is surgery. Share ...
A benign esophageal cell papilloma is a small, noncancerous tumor that forms in the esophagus. Most do not cause symptoms. Doctors treat the growth by removing it. A papilloma is a benign ...
Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...
An interview with Dr. Jessica Geiger from Cleveland Clinic on “Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline.” This guideline provides ...
The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...
Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space were PD-1 inhibitors such as cemiplimab (Libtayo; Regeneron) and ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
Vegetarian-associated ESCC risk (HR 1.93) remained robust after excluding the first four follow-up years and restricting to never-smokers, reducing likelihood of reverse causation and smoking ...